ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
Study on predicting microsatellite instability in rectal cancer using T
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the feasibility of T₂ mapping combined with apparent diffusion coefficient (ADC) value for preoperatively predicting microsatellite instability (MSI) status in rectal cancer.
methodsThis retrospective study included 152 patients with pathologically confirmed rectal cancer (40 MSI, 112 microsatellite stable [MSS]). All patients underwent MRI including T₂ mapping and diffusion-weighted imaging (DWI). Tumor T₂ and ADC values were measured and compared. A combined prediction model was constructed using multivariate logistic regression with SMOTE oversampling and L2 regularization. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis, with model stability assessed via 10-fold cross-validation and Bootstrap resampling (1000 times).
resultsThe MSI group had a significantly lower T₂ value (92.18 ± 7.21 ms vs. 99.47 ± 7.85 ms, p < 0.001) and a higher ADC value (1.06 ± 0.18 vs. 0.91 ± 0.19 × 10⁻³ mm²/s, p < 0.001) compared to the MSS group. The AUC for predicting MSI status was 0.865 for T₂ value and 0.741 for ADC value. The combined model significantly improved the AUC to 0.915 (95% CI: 0.865–0.965), with a sensitivity of 82.5% and specificity of 89.3%. The model demonstrated excellent stability (Bootstrap mean AUC = 0.913).
conclusionT₂ mapping combined with ADC value provides a reliable, non-invasive method for preoperative prediction of MSI status in rectal cancer. The combined model demonstrates higher diagnostic efficacy than either parameter alone and shows promising potential for clinical translation to support precision treatment decision-making in conjunction with histopathological assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.